Aurinia Pharmaceuticals Inc (AUPH)

[CoolG73]

of course, this is a very bullish signal since it shows you the AURORA trial will be a success because you will be comparing to a Placebo CR of around 20%, also it shows you that you are better than the competition ( CR of 38% vs 49% with faster CR with VCS). the only difference is that Roche got the Break through status from FDA and we didn't because of the Safety issues we had in AURA ( this should be solved in AURORA), and the major difference is that ROCHE study is for WHITE and HISPANIC while AURORA is Global ( they don't have Black or Chinese)